Class II Transactivator (CIITA) Deficiency in Tumor Cells: Complicated Mechanisms or Not?

Peter J. van den Elsen(Leiden University Medical Center), Takuya Yazawa(Dokkyo Medical University)

American Journal Of Pathology

July 1, 2003

10.1016/s0002-9440(10)63664-4

Cited by 7

Related Papers

HLA-G Transactivation by cAMP-response Element-binding Protein (CREB)

|Journal of Biological Chemistry|2002|65

Transcriptional Regulation of the MHC Class II <i>Trans</i> -Activator (CIITA) Promoter III: Identification of a Novel Regulatory Region in the 5′-Untranslated Region and an Important Role for cAMP-Responsive Element Binding Protein 1 and Activating Transcription Factor-1 in CIITA-Promoter III Transcriptional Activation in B Lymphocytes

|The Journal of Immunology|2002|48

REST Inactivation and Coexpression of ASCL1 and POU3F4 Are Necessary for the Complete Transformation of RB1/TP53-Inactivated Lung Adenocarcinoma into Neuroendocrine Carcinoma

|American Journal Of Pathology|2022|14